Under the Donald Trump presidential administration, the United States Food and Drug Administration approved the generic version of the abortion pill mifepristone

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Law and political conflict over abortion access, contraception, fertility treatment and the medical care surrounding pregnancy in the United States. Returned largely to the states by the Supreme Court's 2022 Dobbs ruling, and fought since through ballot measures, legislatures and courts.